$3.79
0.52% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US64131A1051
Symbol
STIM

Neuronetics, Inc. Stock price

$3.79
-0.66 14.74% 1M
+2.67 238.39% 6M
+2.18 135.40% YTD
+1.73 83.98% 1Y
+1.89 99.47% 5Y
-23.99 86.36% 10Y
-23.99 86.36% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.02 0.52%
ISIN
US64131A1051
Symbol
STIM

Key metrics

Market capitalization $249.46m
Enterprise Value $284.58m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.18
P/S ratio (TTM) P/S ratio 2.79
P/B ratio (TTM) P/B ratio 7.04
Revenue growth (TTM) Revenue growth 22.17%
Revenue (TTM) Revenue $89.45m
EBIT (operating result TTM) EBIT $-43.15m
Free Cash Flow (TTM) Free Cash Flow $-37.29m
Cash position $20.22m
EPS (TTM) EPS $-0.78
P/E forward negative
P/S forward 1.66
EV/Sales forward 1.89
Short interest 7.37%
Show more

Is Neuronetics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Neuronetics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Neuronetics, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Neuronetics, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Neuronetics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
89 89
22% 22%
100%
- Direct Costs 33 33
82% 82%
36%
57 57
3% 3%
64%
- Selling and Administrative Expenses 83 83
16% 16%
93%
- Research and Development Expense 8.04 8.04
11% 11%
9%
-41 -41
60% 60%
-46%
- Depreciation and Amortization 2.42 2.42
18% 18%
3%
EBIT (Operating Income) EBIT -43 -43
57% 57%
-48%
Net Profit -49 -49
76% 76%
-54%

In millions USD.

Don't miss a Thing! We will send you all news about Neuronetics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neuronetics, Inc. Stock News

Neutral
GlobeNewsWire
4 days ago
NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company's ongoing commitment to clinical innovation and excellence NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company's ongoing commitment to clinical innovation and excellence
Neutral
GlobeNewsWire
12 days ago
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that it is set to join the broad-market Russell 3000® Index ...
Neutral
Seeking Alpha
about one month ago
Neuronetics, Inc. (NASDAQ:STIM ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President & Chief Executive Officer Steve Furlong - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair William Plovanic - Canaccord Genuity Adam Maeder - Piper Sandler Danny Stauder - Citizens J...
More Neuronetics, Inc. News

Company Profile

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Head office United States
CEO Keith Sullivan
Employees 716
Founded 1998
Website neurostar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today